Notice: Function amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `amp_init` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the plugin with slug `schema-and-structured-data-for-wp` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /home/u885321871/domains/fintechinshorts.com/public_html/wp-includes/functions.php on line 6114

Notice: Function amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `amp_init` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the plugin with slug `schema-and-structured-data-for-wp` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /home/u885321871/domains/fintechinshorts.com/public_html/wp-includes/functions.php on line 6114

Notice: Function amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `init` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the plugin with slug `schema-and-structured-data-for-wp` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /home/u885321871/domains/fintechinshorts.com/public_html/wp-includes/functions.php on line 6114

Notice: Function amp_is_available was called incorrectly. `amp_is_available()` (or `amp_is_request()`, formerly `is_amp_endpoint()`) was called too early and so it will not work properly. WordPress is currently doing the `init` hook. Calling this function before the `wp` action means it will not have access to `WP_Query` and the queried object to determine if it is an AMP response, thus neither the `amp_skip_post()` filter nor the AMP enabled toggle will be considered. It appears the plugin with slug `schema-and-structured-data-for-wp` is responsible; please contact the author. Please see Debugging in WordPress for more information. (This message was added in version 2.0.0.) in /home/u885321871/domains/fintechinshorts.com/public_html/wp-includes/functions.php on line 6114
PYC Therapeutics: Lands FDA clearance for first human trials of RP11 treatment drug | Fintech InShorts: Latest fintech news, analysis by experts

Less than 1 min.Read

PYC Therapeutics: Lands FDA clearance for first human trials of RP11 treatment drug

By Steve Sam

March 6, 2023

PYC Therapeutics Lands FDA clearance for first human trials of RP11 treatment drug

PYC Pharmaceuticals (PYC) lands approval from the US FDA to begin human trials of a new drug to treat the blinding eye disease Retinitis Pigmentosa (RP11)
The genetic disease affects around one in every 100,000 people, and no other treatment options currently exist
PYC will now seek human ethics approval for its VP-001 drug before it kicks off the first human clinical trials for an RP11 treatment
Provided its ethics application goes smoothly, PYC expects to dose the first of 10-15 trial participants before the end of June
PYC shares are up 2.33 per cent and trading at 8.8 cents at 12:48 pm AEDT

Tags
PYC Therapeutics

Hot this week

Topics

Popular Categories

FinTechBankingBusinessFundingAIPaymentsPartnership

Binance: Adds support for more African currencies

Australian Strategic Materials: Appoints Rowena Smith as Managing Director

PYC Therapeutics: Lands FDA clearance for first human trials of RP11 treatment drug

PYC Therapeutics Lands FDA clearance for first human trials of RP11 treatment drug

Banking as a Service: Meaning, Examples, Benefits and Future

Best fintech blogs and websites

What is Fintech?

How to buy shares online

Is it worth investing in life insurance over 60?

Topics

Singapore-based fintech start-up WSPN bags $30m seed funding

Mastercard set to lay off around 3% of global workforce

HSBC reportedly considering sale of its South African business

ABN Amro goes live with CBA’s IBAS TDD software and nCino’s cloud banking platform

USAA president and CEO Wayne Peacock to retire in 2025

Singapore’s Valverde taps Broadridge for investment management solution

US fintech Amount lands $30m in fresh funding to advance AI capabilities

Sharon Naidoo named new TransUnion CFO for the UK and Europe

Related Articles

Singapore-based fintech start-up WSPN bags $30m seed funding

Mastercard set to lay off around 3% of global workforce

HSBC reportedly considering sale of its South African business

ABN Amro goes live with CBA’s IBAS TDD software and nCino’s cloud banking platform

USAA president and CEO Wayne Peacock to retire in 2025

Company

Headlines

Singapore-based fintech start-up WSPN bags $30m seed funding

Mastercard set to lay off around 3% of global workforce

HSBC reportedly considering sale of its South African business

ABN Amro goes live with CBA’s IBAS TDD software and nCino’s cloud banking platform

Newsletter